Mirae Asset Global Investments Co. Ltd. Purchases 14,890 Shares of Unum Group (NYSE:UNM)

Mirae Asset Global Investments Co. Ltd. boosted its position in Unum Group (NYSE:UNM) by 13.3% in the 4th quarter, Holdings Channel reports. The firm owned 127,163 shares of the financial services provider’s stock after buying an additional 14,890 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Unum Group were worth $9,307,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in UNM. Versant Capital Management Inc raised its stake in shares of Unum Group by 26.4% during the fourth quarter. Versant Capital Management Inc now owns 766 shares of the financial services provider’s stock valued at $56,000 after acquiring an additional 160 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. raised its stake in shares of Unum Group by 28.8% during the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 800 shares of the financial services provider’s stock valued at $58,000 after acquiring an additional 179 shares in the last quarter. CIBC Asset Management Inc raised its stake in shares of Unum Group by 3.4% during the third quarter. CIBC Asset Management Inc now owns 5,551 shares of the financial services provider’s stock valued at $330,000 after acquiring an additional 180 shares in the last quarter. V Square Quantitative Management LLC raised its stake in shares of Unum Group by 38.2% during the third quarter. V Square Quantitative Management LLC now owns 702 shares of the financial services provider’s stock valued at $42,000 after acquiring an additional 194 shares in the last quarter. Finally, Brooklyn Investment Group raised its stake in shares of Unum Group by 3.1% during the third quarter. Brooklyn Investment Group now owns 6,592 shares of the financial services provider’s stock valued at $392,000 after acquiring an additional 197 shares in the last quarter. Institutional investors own 86.57% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on UNM shares. Barclays lifted their price target on shares of Unum Group from $76.00 to $85.00 and gave the company an “overweight” rating in a research note on Monday, January 6th. Evercore ISI raised shares of Unum Group from an “in-line” rating to an “outperform” rating and lifted their price target for the company from $67.00 to $84.00 in a research note on Thursday, November 14th. Morgan Stanley lifted their price target on shares of Unum Group from $62.00 to $64.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 30th. Truist Financial boosted their price objective on shares of Unum Group from $70.00 to $75.00 and gave the stock a “buy” rating in a research note on Friday, November 1st. Finally, Wells Fargo & Company boosted their price objective on shares of Unum Group from $74.00 to $81.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 14th. Five equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $79.45.

Unum Group Price Performance

NYSE UNM opened at $76.62 on Friday. The firm’s fifty day simple moving average is $74.24 and its two-hundred day simple moving average is $65.08. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.32. Unum Group has a 12-month low of $46.64 and a 12-month high of $79.43. The firm has a market capitalization of $13.99 billion, a P/E ratio of 8.29, a P/E/G ratio of 1.08 and a beta of 0.80.

Unum Group (NYSE:UNM) last released its quarterly earnings results on Tuesday, February 4th. The financial services provider reported $2.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.14 by ($0.11). Unum Group had a return on equity of 15.21% and a net margin of 13.76%. Analysts forecast that Unum Group will post 8.54 EPS for the current fiscal year.

Unum Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Friday, January 24th will be issued a $0.42 dividend. This represents a $1.68 annualized dividend and a yield of 2.19%. The ex-dividend date of this dividend is Friday, January 24th. Unum Group’s dividend payout ratio is currently 17.74%.

Insiders Place Their Bets

In other news, Director Hanley Ronald P. O sold 14,299 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $72.10, for a total transaction of $1,030,957.90. Following the sale, the director now directly owns 38,819 shares of the company’s stock, valued at $2,798,849.90. The trade was a 26.92 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Timothy Gerald Arnold sold 10,000 shares of the business’s stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $76.92, for a total transaction of $769,200.00. Following the sale, the executive vice president now directly owns 54,827 shares in the company, valued at $4,217,292.84. This trade represents a 15.43 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 98,164 shares of company stock valued at $7,346,040. 0.93% of the stock is currently owned by insiders.

Unum Group Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.